Erratum: Phase I Trial of GD2.CART Cells Augmented With Constitutive Interleukin-7 Receptor for Treatment of High-Grade Pediatric CNS Tumors

F Frank Y. Lin A Austin Stuckert C Candise Tat M Mark White L Lucia Ruggieri H Huimin Zhang B Birju Mehta N Natalia Lapteva Z Zhuyong Mei A Angela Major S Sachin Thakkar T Thomas Shum K Kathan Parikh M Meng-Fen Wu H Holly B. Lindsay L Lauren Scherer M Meghan Shekar D Darryl Kinnear M Melissa M. Blessing P Patricia Baxter T Tao Wang B Bambi Grilley (1Baylor College of Medicine, Houston, United States) K Karen Moeller J John Hicks (2Texas Children's Hospital, Houston, United States) A Angshumoy Roy (1Baylor College of Medicine, Pathology & Immunology, Houston, United States) J Jamie Anastas F Fatema Malbari G Guillermo Aldave M Murali Chintagumpala S Susan Blaney D D. Williams Parsons (1Department of Genetics and Genomics, Baylor College of Medicine, Houston, TX) M Malcolm K. Brenner H Helen E. Heslop (3Baylor College of Medicine) C Cliona M. Rooney B Bilal Omer (Texas Children’s Hospital)